ITGB6 and Duchenne muscular dystrophy: Excessive TGFβ signaling is thought to contribute to detrimental changes in muscle functional properties in diseases like Duchenne Muscular Dystrophy and therefore regulation of ITGB6 activity may represent a fruitful area for drug discovery research.